Does VEDOLIZUMAB Cause Rectal discharge? 140 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 140 reports of Rectal discharge have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.2% of all adverse event reports for VEDOLIZUMAB.
140
Reports of Rectal discharge with VEDOLIZUMAB
0.2%
of all VEDOLIZUMAB reports
0
Deaths
34
Hospitalizations
How Dangerous Is Rectal discharge From VEDOLIZUMAB?
Of the 140 reports, 34 (24.3%) required hospitalization, and 2 (1.4%) were considered life-threatening.
Is Rectal discharge Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 140 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Rectal discharge?
ORLISTAT (475)
ALLI (183)
ADALIMUMAB (166)
INFLIXIMAB (42)
MESALAMINE (25)
INFLIXIMAB-DYYB (23)
OMEPRAZOLE (19)
POLYETHYLENE GLYCOL 3350 (18)
RANITIDINE (15)
UPADACITINIB (15)
Which VEDOLIZUMAB Alternatives Have Lower Rectal discharge Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB